Yungjin Pharmaceutical Co., Ltd. logo

Yungjin Pharmaceutical Co., Ltd. (003520)

Market Closed
12 Jun, 06:30
KRX SM KRX SM
1,265. 00
+24
+1.9339%
363.22B Market Cap
- P/E Ratio
- Div Yield
237,311 Volume
- Eps
1,241
Previous Close
Add Transaction
Day Range
1,245 1,293
Year Range
1,203 2,450
Want to track 003520 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

003520 closed Friday higher at ₩1,265, an increase of 1.9339% from Thursday's close, completing a monthly decrease of -2.6174% or -₩34. Over the past 12 months, 003520 stock lost -36.9077%.
003520 is not paying dividends to its shareholders.
The last earnings report, released on May 05, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Yungjin Pharmaceutical Co., Ltd. has completed 5 stock splits, with the recent split occurring on Jun 18, 2010.
The company's stock is traded on one exchange.

003520 Chart

People also search for

Hyundai Motor Co.
647,000
+6.5898%
Hyundai Motor Co. Ltd.
244,500
+4.9356%
Hyundai Motor Co. Ltd. Preferred
256,500
+6.2112%
Hyundai Motor Co., Ltd. Preferred
257,000
+6.639%
Kia Corporation
167,500
+0.4197%

Yungjin Pharmaceutical Co., Ltd. (003520) FAQ

What is the stock price today?

The current price is ₩1,265.00.

On which exchange is it traded?

Yungjin Pharmaceutical Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 003520.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 363.22B.

Has Yungjin Pharmaceutical Co., Ltd. ever had a stock split?

Yungjin Pharmaceutical Co., Ltd. had 5 splits and the recent split was on Jun 18, 2010.

Yungjin Pharmaceutical Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. GiSu Lee CEO
KRX SM Exchange
KR7003520004 ISIN
KR Country
574 Employees
3 Jan 1997 Last Dividend
18 Jun 2010 Last Split
- IPO Date

Overview

Yungjin Pharm. Co., Ltd. is a prominent pharmaceutical company with a base in South Korea, extending its operations globally. The firm has been in the pharmaceutical industry since its inception in 1952, showcasing a longstanding history of providing healthcare solutions. It prides itself on a wide range of pharmaceutical products that cater to various therapeutic areas. Furthermore, Yungjin Pharm. Co., Ltd. operates under the umbrella of KT&G Corporation, which denotes a significant backing and strategic partnership that enhances its capabilities and market reach. The headquarters of Yungjin Pharm. is situated in Seoul, South Korea, positioning it strategically within one of the country's pivotal economic and scientific research hubs.

Products and Services

Yungjin Pharm. Co., Ltd. offers a comprehensive array of pharmaceutical products and services that span across several key health and wellness sectors. These include:

  • Cephalosporin Antibiotic Products: This segment focuses on developing and distributing cephalosporin, a class of antibiotics used widely to treat a range of bacterial infections.
  • Antipsychotic Products: Yungjin Pharm specializes in antipsychotic medications intended for the treatment and management of psychiatric disorders, helping improve mental health conditions.
  • Cardiovascular Products: The company provides a variety of cardiovascular drugs aimed at treating heart and blood vessel conditions, supporting heart health and function.
  • Gastrointestinal Products: This range includes treatments for the digestive system, offering solutions for diseases pertaining to the gastrointestinal tract.
  • Metabolic Products: Yungjin Pharm offers medications targeted at metabolic disorders, which affect the body's ability to convert food into energy efficiently.
  • Neuropsychiatry Products: The company’s portfolio includes treatments for neurological and psychiatric conditions, encompassing both brain disorders and mental health issues.
  • Respiratory Products: This category covers medicines for respiratory conditions, catering to diseases affecting the lungs and breathing.
  • Infectious Products: Yungjin Pharm provides treatments for infectious diseases, focusing on combating infections caused by bacteria, viruses, fungi, or parasites.
  • Anti-inflammatory and Analgesics: The company offers products with anti-inflammatory and pain-relieving properties, targeting conditions that cause pain and swelling.
  • Nutritional Supplement Products: A range of vitamins, minerals, and nutritional supplements designed to support overall health and well-being.
  • Urology Products: Yungjin Pharm also specializes in the field of urology, offering treatments for urinary tract and male reproductive organ disorders.
  • Vitamins, Minerals, and Other Products: Besides pharmaceuticals, Yungjin Pharm produces a variety of vitamins and mineral supplements catering to general health needs.
  • APIs (Active Pharmaceutical Ingredients): The company is involved in the manufacturing and supply of Active Pharmaceutical Ingredients, which are critical components for the production of various drugs.

Contact Information

Address: Jamsil Company Building, Seoul, South Korea, 05510
Phone: 82 2 2041 8200